These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16015691)

  • 1. Effect of itopride, a new prokinetic, in patients with mild GERD: a pilot study.
    Kim YS; Kim TH; Choi CS; Shon YW; Kim SW; Seo GS; Nah YH; Choi MG; Choi SC
    World J Gastroenterol; 2005 Jul; 11(27):4210-4. PubMed ID: 16015691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of itopride on oesophageal motility and lower oesophageal sphincter function in man.
    Scarpellini E; Vos R; Blondeau K; Boecxstaens V; Farré R; Gasbarrini A; Tack J
    Aliment Pharmacol Ther; 2011 Jan; 33(1):99-105. PubMed ID: 21083582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of new gastro-intestinal prokinetic (ENGIP-I) study.
    Walwaikar PP; Kulkarni SS; Bargaje RS
    J Indian Med Assoc; 2005 Oct; 103(10):559-60. PubMed ID: 16498771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative data of prokinetics in treatment of gastroesophageal reflux disease in patients with diabetes].
    Fedorchenko IuL
    Eksp Klin Gastroenterol; 2013; (5):42-8. PubMed ID: 24501946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease.
    Ruth M; Hamelin B; Röhss K; Lundell L
    Aliment Pharmacol Ther; 1998 Jan; 12(1):35-40. PubMed ID: 9692698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of itopride in the symptoms of functional dyspepsia in Russia: results of a phase IV prospective open-label multicenter clinical trial].
    Kas'ianenko VI; Denisov NL; Vasil'ev IuV
    Ter Arkh; 2014; 86(8):35-41. PubMed ID: 25306742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of itopride hydrochloride and ranitidine in patients with functional dyspepsia: comparison between prokinetic and acid suppression therapies.
    Chiba T; Tokunaga Y; Ikeda K; Takagi R; Chishima R; Terui T; Kudara N; Endo M; Inomata M; Orii S; Suzuki K
    Hepatogastroenterology; 2007 Sep; 54(78):1878-81. PubMed ID: 18019739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranitidine Can Potentiate The Prokinetic Effect Of Itopride At Low Doses- An In Vitro Study.
    Butt AI; Khan BT; Khan A; Khan QU
    J Ayub Med Coll Abbottabad; 2017; 29(4):554-558. PubMed ID: 29330976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia.
    Sawant P; Das HS; Desai N; Kalokhe S; Patil S
    J Assoc Physicians India; 2004 Aug; 52():626-8. PubMed ID: 15847356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A placebo-controlled trial of itopride in functional dyspepsia.
    Holtmann G; Talley NJ; Liebregts T; Adam B; Parow C
    N Engl J Med; 2006 Feb; 354(8):832-40. PubMed ID: 16495395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers.
    Choung RS; Talley NJ; Peterson J; Camilleri M; Burton D; Harmsen WS; Zinsmeister AR
    Neurogastroenterol Motil; 2007 Mar; 19(3):180-7. PubMed ID: 17300287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itopride in treatment of laryngopharyngeal symptoms of gastroesophageal reflux disease.
    Janiak M
    Otolaryngol Pol; 2021 Dec; 75(6):38-44. PubMed ID: 35175221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials.
    Talley NJ; Tack J; Ptak T; Gupta R; Giguère M
    Gut; 2008 Jun; 57(6):740-6. PubMed ID: 17965059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of itopride on gastric emptying in longstanding diabetes mellitus.
    Stevens JE; Russo A; Maddox AF; Rayner CK; Phillips L; Talley NJ; Giguère M; Horowitz M; Jones KL
    Neurogastroenterol Motil; 2008 May; 20(5):456-63. PubMed ID: 18179609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does postprandial itopride intake affect the rate of gastric emptying? A crossover study using the continuous real time 13C breath test (BreathID system).
    Nonaka T; Kessoku T; Ogawa Y; Yanagisawa S; Shiba T; Sahaguchi T; Atsukawa K; Takahashi H; Sekino Y; Iida H; Hosono K; Endo H; Sakamoto Y; Koide T; Takahashi H; Tokoro C; Abe Y; Maeda S; Nakajima A; Inamori M
    Hepatogastroenterology; 2011; 58(105):224-8. PubMed ID: 21510319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability and tolerability of combination treatment with revaprazan 200 mg + itopride 150 mg: a randomized crossover study in healthy male Korean volunteers.
    Choi HY; Noh YH; Jin SJ; Kim YH; Kim MJ; Sung H; Jang SB; Lee SJ; Bae KS; Lim HS
    Clin Ther; 2012 Sep; 34(9):1999-2010. PubMed ID: 22858177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Composite score of reflux symptoms in diagnosis of gastroesophageal reflux disease.
    Wang JH; Luo JY; Dong L; Gong J; Zuo AL
    World J Gastroenterol; 2004 Nov; 10(22):3332-5. PubMed ID: 15484311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Itopride in the treatment of functional dyspepsia in Chinese patients: a prospective, multicentre, post-marketing observational study.
    Sun J; Yuan YZ; Holtmann G
    Clin Drug Investig; 2011 Dec; 31(12):865-75. PubMed ID: 22035464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postoperative evaluation of esophageal mucosal change dynamics in patients with reflux diseases].
    Wallner G; Misiuna P; Chibowski D; Polkowski W; Abramowicz K; Sory A
    Wiad Lek; 1997; 50 Suppl 1 Pt 1():273-81. PubMed ID: 9446369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.